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Resume
Background: Obstructive Sleep Apnea (OSA) is a sleep-related 
breathing disorder, leading to decreased quality of life, increased risk 
of cardiovascular morbidity and mortality, increased frequency of 
automobile accidents. Continuous positive airway pressure (CPAP) 
remains the first line of treatment for OSA. Many patients are 
unwilling or incapable to tolerate the treatment and therefore turn 
to surgical options to alleviate symptoms and sequela of the disease. 
Аim: To present our experience in the surgical treatment of OSA.
Materials and Methods: 50 patients (48 male / 2 female) underwent 
surgical treatment for OSA in our clinic for a period of 10 years. 
Subjective complaints were evaluated by interview of the patient 
and partner pre- and postoperatively, with key factors studied being 
snoring level (visual analogue 1–10) and Epworth Sleepiness Scale 
(ESS). Objective data were Body Mass Index (BMI), nasal endoscopy, 
pre and postoperative polysomnographic data, rhinomanometry, 
Mallampati score, diagnostic imaging of the nose and sinuses.
Results: The mean BMI of the patients was 29.8± 3.4. 21 patients 
had nasal obstruction for which they underwent surgical treatment. 5 
patients had micro or retrognathia. 37 Pateints had a Mallampati score 
of 3 and 13 of 4. All 50 patients underwent Uvulopalatopharyngoplasty 
(UPPP) and 6 patients also had Radiofrequency tongue base reduction. 
There were no serious complications. Subjective improvement in the 
severity of the symptoms was obtained in 88% (44) of patients. 
Objective success was obtained in 56% (28) of the patients.
Conclusions: Surgical treatment of OSA leads to a significant 
subjective improvement in the severity of symptoms and acceptable 
objective results. For maximal results a multidisciplinary approach is 
required for the complex treatment of OSA.
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Background
Sleep-related breathing disorders range from partial 
airway collapse and increased upper airway resist-
ance to episodes of hypopnea or complete airway 
collapse. The indices and events used to describe 
sleep-disordered breathing according to Kushida et 
al [1] are presented in table 1, 2 
Table 1. Respiratory events definition and types
Event Definition
Apnea A cessation of  airflow for at least 10 second
Hypopnea A reduction in airflow (≥30%) at least 10 
seconds with ≥4% oxyhemoglobin desatu-
ration OR a reduction in airflow (≥50%) at 
least 10 seconds with ≥3% oxyhemoglobin 






Sequence of  breaths for at least 10 sec-
onds with increasing respiratory effort or 
flattening of  the nasal pressure waveform, 
leading to an arousal from sleep when the 
sequence of  breaths does not meet the cri-
teria for an apnea or a hypopnea
Obstructive 
apnea
Continued thoracoabdominal effort in the 




The lack of  thoracoabdominal effort in the 




A respiratory event with both obstructive 
and central features, with mixed events 
generally beginning as central events and 
ending with thoracoabdominal effort without 
airflow
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Number of  apneas and hypopneas per hour 











Number of  apneas, hypopneas, and RERAs 









Number of  mixed apneas per hour of  total 
sleep time
Obstructive sleep apnea (OSA)
OSA syndrome is defined by five or more respira-
tory events – apneas, hypopneas, or RERAs – in 
association with excessive daytime somnolence; 
waking with gasping, choking, or breath holding; 
or witnessed reports of apneas, loud snoring, or 
both. Each episode of apnea or hypopnea must 
last a minimum of 10 seconds, which is common-
ly accompanied by reductions in blood oxygen 
saturation of at least 3% to 4%, and is usually ter-
minated by brief, unconscious arousals from sleep 
as diagnosed by polysomnography. The American 
Academy of Sleep Medicine classifies mild OSA 
as 5 to 15 events per hour, moderate as 15 to 30 
events, and severe as 30 events or more. 
The most common symptoms are loud snoring, 
daytime hypersomnolence, witnessed episodes of 
apnea, choking or gasping during sleep by bed 
partner. There have also been other symptoms 
connected with OSA such as – morning fatigue 
or irritability, memory loss, decreased cognitive 
function, depression personality or mood changes, 
decreased libido, impotence, morning and noctur-
nal headaches, nocturnal sweating and enuresis.
Pathophysiology
The obstruction that occurs in OSA is a result from 
the collapse of the pharyngeal airway during sleep. 
Its etiology and mechanism is multifactorial but is 
largely due to the interaction of an easily collapsi-
ble upper airway with relaxation of the pharyngeal 
dilator muscles. The collapse can have anatomi-
cal (obesity, retrognatia, soft tissue hypertrophy) 
neuromuscular (reduce patency due to relaxed 
pharyngeal dilatator muscles) causes. The three 
major areas of obstruction are the nose, palate, 
and hypopharynx, although OSA associated with 
laryngeal obstruction (laryngomalacia, billateral 
laryngeal paralysis) has been reported [2]
The genioglossus muscle is considered to be the 
most important muscle in maintaining airway 
patency in OSA. Elevated genioglossal and ten-
sor palatini muscle activity has been observed in 
awake OSA patients compared with normal awake 
subjects who have lower levels of activity. This 
suggests that even while the patient is awake, 
airway dilator muscle activity compensates for a 
more anatomically compromised upper airway in 
the OSA patient. [2]
Nasal obstruction contributes to increased airway 
resistance and may worsen OSA, but it is rarely 
the sole cause. Nasal obstruction may contribute to 
open-mouth breathing during sleep, which increas-
es upper airway collapsibility and may decrease the 
efficacy of dilator muscles. [3]
Consequences of untreated OSA 
A number negative health effects and reduced qual-
ity of life have been attributed to untreated OSA 
including an increased in mortality, cardiovascu-
lar disease (hypertension, coronary heart disease, 
congestive heart failure, arrhythmia, pulmonary 
hypertension, stroke, and sudden death) [4], neu-
rocognitive difficulties [5], insulin resistance and 
metabolic syndrome [6]. Treatment of OSA has a 
positive effect on these comorbidities.
Treatment
The treatment of OSA can be conservative or oper-
ative. Conservative options are continuous positive 
airway pressure (CPAP), oral appliances, nasal 
dilatators, tongue retaining devices. CPAP is con-
sidered the gold standard in the treatment of OSA 
but low patient adherence remains a significant 
obstacle.
Surgical treatment should be considered according 
to the patient’s wishes, CPAP tolerance, severity of 
symptoms, severity of disease, comorbidities, and 
site and severity of upper airway collapse. Many 
patients are either incapable or unwilling to toler-
1/2021  International Bulletin of Otorhinolaryngology
 27
ate CPAP treatment and turn to surgical options to 
alleviate symptoms and sequela of OSA.
Aim
The aim of this study is to present our experience in 
the surgical treatment of OSA.
Material and methods 
We have included 50 (48 male, 2 female) patients for 
a period of 10 years (2010–2020) who underwent 
surgical treatment for OSA in the clinic. Subjective 
complaints were evaluated by interview of the pa-
tient and partner pre- and postoperatively, with key 
factors studied being snoring level (visual analogue 
1–10) and Epworth Sleepiness Scale (ESS). Objec-
tive data were Body Mass Index (BMI), nasal en-
doscopy, pre- and postoperative polysomnographic 
(PSG) data, rhinomanometry, Mallampati score, 
diagnostic imaging of the nose and sinuses. The 
criteria we have chosen for objective success from 
surgical treatment is AHI≤12 or 50% reduction of 
AHI obtained from PSG 3 months post-operatively.
Results 
The mean BMI of the patients was 29.8± 3.4. 18 
(28%) had solely retropalatal obstruction while 32 
(72%) had multilevel obstruction – 5 with micro or 
retrognatia; 21 with nasal obstruction; 6 with retro-
lingual obstruction. 37 (74%) Patients had a Mal-
lampati score of 3 and 13 (26%) of 4. The patients 
with nasal obstruction underwent surgical treat-
ment for it as a first stage. All 50 patients under-
went Uvulopalatopharyngoplasty(UPPP) and for 
the 6 patients with retrolingual obstruction – tongue 
base radiofrequency ablation (TBRF). There were 
no serious complications from the treatment. There 
were 8 (16%) cases of temporary nasal reflux and 
3 (6%) cases of post-operative hemorrhage. 44 
(88%) patients reported subjective improvement in 
the severity of the symptoms based on snoring level 
visual analogue and ESS. The preoperative results 
for snoring level were (7.8±1.2) postoperatively 
(3.4±1); for ESS preoperative (16.2±3) postopera-
tively (8.5±3). Objective success was obtained in 
28 (56%) of patients; 16 (32%) had an improve-
ment in PSG data but did not cover the criteria for 
objective success; 6 (12%) were non-responders.
Discussion
There are many questions still left considering 
surgical treatment of OSA. UPPP is the most 
commonly performed operation for OSA by 
otorhinolaryngolist. Three main factors should 
be considered – 1) the overall low objective suc-
cess from the operation indicated by many stud-
ies; 2) patient selection is crucial for the success 
of the treatment; 3) there is a chance to aggravate 
the symptoms [7]. In our study although there was 
overall low objective success (58%), most patients 
reported reduction in symptoms (88%). We attrib-
ute this to the fact that although the patients didn’t 
cover the criteria for objective success, there was 
an improvement in PSG data and therefore reduc-
tion in subjective symptoms indicated by snoring 
level visual analogue and ESS. The importance of 
patient selection is explored by Fujita et al, Fried-
man et al [8] [9] who proposed staging criteria for 
patients undergoing UPPP for OSA which focus 
on Mallampati score, BMI, tonsil size and the site 
of obstruction as factors for the success of the op-
eration. For us the group with objective success 
included all of the patients with solely retropalatal 
obstruction; BMI ≤29; patients were with moder-
ate to mild OSA with the range being AHI 15–28; 
Mallampati score 3. For the partial responders; all 
had multilevel obstruction, BMI≤35; moderate to 
severe OSA with the range of AHI being 26–35; 9 
patients had a Mallampati score of 3 and 7 Mal-
lampati score of 4. For the non-responders that 
group included all the patients with micrognathia 
or retrognathia; BMI≥35; all patients had severe 
OSA with AHI ≥35. In our clinic we don’t have 
experience with mandibular advancement surgery 
and therefore didn’t treat the site of obstruction 
for the patients with retrognathia or micrognathia. 
Furthermore, the high BMI, multilevel obstruction 
(nasal, retrolingual and retropalatal) and severity 
of OSA were contributing factors for the 6-th pa-
tient in the group. Our findings correspond with 
those of other studies.
Conclusion
Surgical treatment of OSA leads to acceptable ob-
jective results and significant subjective improve-
ment in severity of symptoms in carefully select-
ed patients. Proper identification of the site of ob-
struction and selecting surgical treatment targeting 
the site is the key to success. Multidisciplinary 
approach is required for the complex treatment of 
OSA.
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